GlassScriptPhysician profile
Michelle Mozatto
NPI 1649754680
$3,343.83
in general payments reported to CMS, 2019-2025
37 companies · $943 in 2025
The $943 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $660 · 2022: $638 · 2023: $522 · 2024: $581 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $529.19 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $428.07 | 2021-2025 | |
| Genentech USA, INC. | $218.81 | 2021-2025 | Xolair |
| Glaxosmithkline, LLC. | $213.16 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $155.89 | 2021-2022 | |
| Pharming Healthcare, INC. | $145.59 | 2022-2023 | Ruconest |
| Genzyme Corporation | $134.90 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.38 | 2021-2024 | Hyqvia, Glassia |
| Incyte Corporation | $105.68 | 2025 | Opzelura |
| Kaleo, INC. | $95.16 | 2023-2024 | Auvi-Q |
| Pfizer INC. | $89.72 | 2021 | |
| Ucb, INC. | $87.98 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $80.45 | 2022-2025 | Dupixent |
| Organon LLC | $73.62 | 2025 | Vtama |
| Janssen Biotech, INC. | $72.22 | 2025 | Tremfya |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $71.93 | 2025 | Nemluvio |
| Octapharma USA, INC. | $68.69 | 2024 | Panzyga |
| Sun Pharmaceutical Industries INC. | $65.61 | 2025 | |
| Convatec INC. | $58.78 | 2025 | |
| Lilly USA, LLC | $57.64 | 2025 | Ebglyss, Taltz |
| Tersera Therapeutics LLC | $46.75 | 2022 | |
| Grifols USA, LLC | $44.35 | 2024 | Xembify |
| Organogenesis INC. | $43.09 | 2025 | Puraply Wound Matrix |
| Adma Biomanufacturing LLC | $41.08 | 2021 | |
| Amgen INC. | $40.79 | 2022-2023 | Tezspire |
| Leo Pharma INC. | $35.97 | 2025 | Adbry, Anzupgo |
| Philips North America LLC | $34.41 | 2023 | |
| Hikma Pharmaceuticals USA | $24.62 | 2024 | Ryaltris |
| Astrazeneca Pharmaceuticals LP | $23.79 | 2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.41 | 2025 | Spevigo |
| Merck Sharp & Dohme LLC | $21.39 | 2024 | Capvaxive |
| Aimmune Therapeutics, INC. | $18.72 | 2022 | |
| Almirall LLC | $16.88 | 2025 | Seysara |
| Abbvie INC. | $16.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $16.51 | 2025 | Sotyktu |
| Ars Pharmaceuticals Operations, INC. | $16.33 | 2025 | Neffy |
| Helsinn Therapeutics (U.S.), INC. | $15.39 | 2025 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Mozatto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.